In vitro cellular immunity and in vivo delayed hypersensitivity in uremic patients maintained on hemodialysis.
D001379:Azathioprine / Q000627:therapeutic use; D005260:Female; D005921:Glomerulonephritis / Q000276:immunology; D006084:Graft Rejection; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D066298:In Vitro Techniques; D016030:Kidney Transplantation; D037102:Lectins; D007959:Lymphocyte Culture Test, Mixed; D008214:Lymphocytes / Q000276:immunology; D008297:Male; D008934:Mitogens; D007690:Polycystic Kidney Diseases / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use; D011704:Pyelonephritis / Q000276:immunology; D006435:Renal Dialysis; D012882:Skin Tests; D013936:Thymidine / Q000378:metabolism; D014184:Transplantation, Homologous; D014316:Tritium; D014511:Uremia / Q000276:immunology* / Q000628:therapy
D037102:Lectins; D008934:Mitogens; D014316:Tritium; D001379:Azathioprine; D011241:Prednisone; D013936:Thymidine